Broodkruimel
Documenten en Media
Cured today, ill tomorrow - a method for including future unrelated medical costs in economic evaluation in England & Wales
Cured today, ill tomorrow - a method for including future unrelated medical costs in economic evaluation in England & Wales
Versie 1.3 Goedgekeurd- Documenttype
- EXTERNAL_DOCUMENT
- Extensie
- png
- Grootte
- 343 kB
- Gewijzigd
- 21-10-22 12:24 door Test Test
- Gemaakt
- 21-10-22 12:06 door Test Test
- Locatie
- PUBLIC
- Waarderingen
-
-
Versie 1.3Door Test Test, over 21-10-22 12:07Geen wijzigingslogboek
-
Versie 1.2Door Test Test, over 21-10-22 12:07Geen wijzigingslogboek
-
Versie 1.1Door Test Test, over 21-10-22 12:07Geen wijzigingslogboek
-
Versie 1.0Door Test Test, over 21-10-22 12:06Geen wijzigingslogboek
Samenvatting
Objectives: In many countries, future unrelated medical costs occurring during life-years gained are excluded from economic evaluation, and benefits of unrelated medical care are implicitly included, leading to life-extending interventions being disproportionately favored over quality of life-improving interventions. This article provides a standardized framework for the inclusion of future unrelated medical costs and demonstrates how this framework can be applied in England and Wales.
Methods: Data sources are combined to construct estimates of per-capita National Health Service spending by age, sex, and time to death, and a framework is developed for adjusting these estimates for costs of related diseases. Using survival curves from 3 empirical examples illustrates how our estimates for unrelated National Health Service spending can be used to include unrelated medical costs in cost-effectiveness analysis and the impact depending on age, life-years gained, and baseline costs of the target group.
Results: Our results show that including future unrelated medical costs is feasible and standardizable. Empirical examples show that this inclusion leads to an increase in the ICER of between 7% and 13%.
Conclusions: This article contributes to the methodology debate over unrelated costs and how to systematically include them in economic evaluation. Results show that it is both important and possible to include future unrelated medical costs.
Keywords: economic evaluation, future costs, NICE, unit costs.
Het COMPAR-EU project heeft financiering ontvangen van het Horizon 2020 onderzoeks- en innovatieprogramma van de Europese Unie in het kader van subsidie overeenkomst nummer 754936.
Houd er rekening mee dat dit de bètaversie van het COMPAR-EU-platform is. Het bevat nu de voltooide resultaten voor Diabetes Type 2 en gedurende de zomer van 2022 zullen de resultaten voor obesitas, COPD en hartfalen worden voltooid. Ook wordt het platform de komende maanden uitgebreid en verbeterd.